Discreet, evidence-based assessment and treatment for erectile dysfunction. ED is often a marker of underlying cardiovascular or hormonal disease — we assess and treat the whole picture.
Book a consultation →Erectile dysfunction affects approximately 40% of men over 40 and is significantly under-treated. Critically, ED is a recognised independent risk factor for cardiovascular disease — new-onset ED in a man under 60 should prompt cardiovascular risk assessment, not just a prescription for sildenafil.
At Metovia we assess the underlying causes thoroughly before and alongside any treatment.
Assessment follows EAU (European Association of Urology) guidelines on male sexual dysfunction, BSSM recommendations for ED assessment, and NICE CG136. All new patients receive cardiovascular risk stratification — ED without vascular assessment is incomplete medicine.
All consultations are completely confidential. We offer video and telephone consultations as well as face-to-face appointments.
Full assessment including cardiovascular risk review, blood tests and treatment plan
Book now →
Dr Qurbain is a Fellow of the Faculty of Pharmaceutical Medicine (FFPM) — one of approximately 700 in the UK. This qualification represents the highest level of expertise in pharmaceutical medicine, covering drug development, clinical pharmacology and evidence-based prescribing.
Unlike nurse-led or questionnaire-only services, every Metovia patient is assessed and prescribed by a doctor with specialist qualifications. Dr Qurbain reviews your full clinical picture — history, comorbidities, medications and risk factors — before any treatment is agreed.
Every consultation is led personally by Dr Qurbain. No junior doctors, no rushed appointments, no templates.